Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

Off-label Use Of Approved Drugs To Treat COVID-19

Concerning the ability of certain health-care providers to repurpose therapeutic drugs that have been approved by the federal food and drug administration for another purpose to provide treatment to individuals with COVID-19.
2022 Regular Session
Health Care & Health Insurance
Professions & Occupations
Bill Summary

The bill specifies that:

  • A physician, physician assistant, or advanced practice registered nurse with prescriptive authority may prescribe and dispense, and a pharmacist may dispense, therapeutic drugs for off-label use, including hydroxychloroquine sulfate and ivermectin, to provide prophylaxis or outpatient (at-home) and inpatient (hospital) treatment to an individual with COVID-19; and
  • This practice is not unprofessional conduct or otherwise grounds for discipline.
    (Note: This summary applies to this bill as introduced.)




Bill Text

Colorado legislature email addresses ending in are no longer active. Please replace with for Colorado legislature email addresses. Details

The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details